Etrasimod (Velsipity®)

Clinical Indication

Severely active ulcerative colitis

Comments

In line with NICE TA956

Date of classification

April 2024

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.